KR900001072B1 - Process for axtraction of cassia tora l. - Google Patents

Process for axtraction of cassia tora l. Download PDF

Info

Publication number
KR900001072B1
KR900001072B1 KR1019870010208A KR870010208A KR900001072B1 KR 900001072 B1 KR900001072 B1 KR 900001072B1 KR 1019870010208 A KR1019870010208 A KR 1019870010208A KR 870010208 A KR870010208 A KR 870010208A KR 900001072 B1 KR900001072 B1 KR 900001072B1
Authority
KR
South Korea
Prior art keywords
extract
ethanol
water
cassia tora
added
Prior art date
Application number
KR1019870010208A
Other languages
Korean (ko)
Other versions
KR890004615A (en
Inventor
김중만
Original Assignee
김중만
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김중만 filed Critical 김중만
Priority to KR1019870010208A priority Critical patent/KR900001072B1/en
Publication of KR890004615A publication Critical patent/KR890004615A/en
Application granted granted Critical
Publication of KR900001072B1 publication Critical patent/KR900001072B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Alcoholic Beverages (AREA)
  • Preparation Of Fruits And Vegetables (AREA)

Abstract

An extraction method of cassia tora L. is provided. Thus, selected cassia tora L. is treated at 150-210oC for a few min, crushed (5-10 mesh), dissolved in water, boiled, and extracted. The cassia tora L. cake is treated with 3-4 times of 30-50% ethanol and extracted with stirring at room temperature for 12-24 hrs to give a final product.

Description

결명자 추출물의 제조방법Method of Preparation of Clarifier Extract

제1도 결명자 전처리.The first degree predicate treatment.

제2도 결명자 추출물 제조과정 1) 수추출액 제조과정 2) 에탄올 추출액 제조과정.Figure 2 Process for producing Cassiae extract 1) Water extract manufacturing process 2) Ethanol extract manufacturing process.

제3도 탄산음료 제조과정.Third process for producing carbonated beverages.

본 발명은 한방에서 청간(淸肝), 명목(明目), 혈압강하, 변비등의 처방재료로 쓰이는 결명자중의 유효성분을 추출함에 있어, 약리적 성분을 상온에서 거의 추출되게 하면서 방수성 및 저장성과, 대량추출이 가능하도록 한 결명자 추출물의 제조방법에 관한 것이다.In the present invention, in extracting the active ingredient in the deficiency used as a prescription material such as blue liver, nominal blood pressure, constipation, etc. in one shot, while the pharmacological components are almost extracted at room temperature, waterproof and storage properties , Relates to a method for preparing the extract of the Clarifier to enable mass extraction.

결명자(학명 : Cassia tora L,)는 콩과에 속하는 1년생 초본인 초결명의 성숙한 껍질은 윤이나고 천립중은 약 32g이다. 일반적으로 결명자는 약간 볶아서 물에넣어 끓여 차로 만들어 음용하는데 색은 황갈색이고 맛은 약간 쓰며 냄새는 알로애 냄새를 내고 있어서 색, 향 미에 있어서 다른차에 비해서 손색이 없다.Cassia tora L, is a 1 year-old herb belonging to the legumes. In general, the deficiency is slightly roasted, put it in water, and boiled it to make tea. The color is yellowish brown, the taste is slightly bitter, and the smell smells like aloe, so it is inferior to other teas in color and flavor.

한방서에 소개된 결명자중의 약리성분을 보면 비타민A의 전구체인(Carotene(C40 h56), 노란색을 띠며 알로애향과 쓴맛을 내는 Alloin(C21 H22 O4), 역시 노란색을 내는 Rhein(C15 H8 O6) 및 Emodin(C15 H10 O5), Chrysophanol, Aloe-emodin, physcion, Obtusin, Aurantio-obtusin, Rubrofusarin, torachryson, Toralactone 등이 들어있어서 결명자 수추출액은 황갈색이고 쓴맛을 내고 독특한 냄새를 느끼게하는 특징이 있다.The pharmacological components of the deficiencies introduced in Oriental medicine include vitamin A precursor (Carotene (C40 h56)), yellow alloin (C21 H22 O4) with aloe flavor and bitter taste, and Rhein (C15 H8 O6) with yellow color. And Emodin (C15 H10 O5), Chrysophanol, Aloe-emodin, physcion, Obtusin, Aurantio-obtusin, Rubrofusarin, torachryson, Toralactone and so on.

이들 성분들의 약리적 효과를 보면 Carotene은 시신경자극과 전달에 필수성분으로 좋은 시력 유지에 유효하고, Alloin은 혈중의 Cholesterol 함량을 낮추어줌은 물론 혈압강하에도 유효한 성분으로 알려지고 있다.The pharmacological effect of these ingredients is that Carotene is an essential ingredient for optic nerve stimulation and delivery, and it is effective for maintaining good vision, and Alloin is known to lower blood Cholesterol content and to lower blood pressure.

기타 결명자의 종합적인 효과로는 간과 콩팥의 이뇨작용을 도와주며 장의 열을 내며 변비를 예방치료하는 효과가 있다.Comprehensive effect of other deficiency is to help the diuretic effect of liver and kidneys, and intestinal fever to prevent constipation effect.

이렇게 결명자는 성분상의 특성이 있고 지금까지 결명자차가 국민의 입맛에 적응되어온 점에 비추어 볼때 결명자차의 이용정도는 의외로 저조한 상태라고 본다. 이와 같이 저조한 이용도는 결명자차를 음용함에 간편화가 되어 있지 않고, 청량음료수타입의 음료에 선호도가 높은 소비자의 취향에 부합하는 특성이 구비되지 못했기 때문이다. 최근 시력이 낮은 어린이와 학생수가 급증하는 추세이고, 시험공부에 학생들이 눈을 혹사하고 있을뿐만 아니라, 고혈압, 동맥경화 및 뇌졸증에 의한 사망률이 증가하여 긴장에 의한 변비환자도 의외로 많은 현실을 고려할 때 결명자차의 대중화는 매우 바람직한 일이다.In view of the fact that the defectors have the characteristics of ingredients and until now, the use of them is surprisingly low. This low availability is not because the drinking tea is not simplified, and the soft drink type of beverage is not provided with characteristics that meet the taste of consumers with high preference. In recent years, the number of children and students with low vision has been increasing rapidly, and students are suffering from hypertension, arteriosclerosis and stroke due to not only overworked students, but also constipation due to tension. Popularization of the missing car is very desirable.

그런데, 각 가정에서는 현재 결명자를 물과 함께 끓여 결명자차로 애용하고 있긴 하나, 결명자 내에 함유되어 있는 약리성분은 100℃물로써 끓인다해도, 결명자중의 약리성분들은 구조중에 -OH, -COOH를 가지고 있어서 물, ethanol, methanol 같은 극성용매에 약간 녹긴하나, 추출용재로서 물을 사용할 경우에는 100℃에서 장시간 가열하여야만 용출의 정도가 약간 커지게 되므로, 이때에는 많은 가열에너지가 필요하게 되고 관리의 어려움이 클뿐아니라 장시간 고온가열이 행해지므로 약리성분들이 파괴되어 반감되는 폐단이 따르게되고, 그리고, methanol 로서 추출하게 될 경우에는, 추출물 중에 인체에 해로운 물질이 잔류하게 되어 유해한 결점이 있다. 또한, 물을넣어 끓여 추출하면 전분이나 단백질이 용액중에 분산되어, 걸러진 상등수라 할지라도, 그 상등수 내에는 부유물질이 많이 포함되어 있어서, 결명자차가 지니는 고유한 색깔을 청명하게 띌 수 없을 뿐만 아니라 끓인 후 부유물질을 강제로 걸러야하는 등의 번거로움이 있게된다. 이상의 문제점 때문에 결명자차가 약리작용이 우수함에도 불구하고 대중화되지 못하고있는 점등의 결점이 있었다.By the way, each household currently boils the defector with water and uses it as a tea of tea, but even if the pharmacological ingredients contained in the fruit are boiled with water at 100 ℃, the pharmacological ingredients in the family have -OH and -COOH in the structure. It is slightly soluble in polar solvents such as water, ethanol and methanol. However, when water is used as an extractant, it is required to heat at 100 ° C for a long time, so that the elution is slightly increased. This requires a lot of heating energy and difficulty in management. However, since high temperature heating is performed for a long time, pharmacological components are destroyed and halved, and when extracted as methanol, harmful substances remain in the extract, which is harmful. In addition, when boiled and extracted with water, starch or protein is dispersed in the solution, and even the filtered supernatant contains a large amount of suspended solids, so that the unique color of the deficiency tea cannot be clearly seen. After that, there is the hassle of forced filtering of suspended solids. Because of the above problems, there was a flaw in the lighting, which was not popularized despite the excellent pharmacological action.

본 발명은, 이러한 결점을 해소하기 위한 것으로, 즉 결명자 내의 약리성분을 상온에서 대량으로 거의 추출하게되고, 추출용액의 청명도가 우수하여 여과 과정이 간편하며, 동시에 방부성이 뛰어나 저장성이 양호한 엑키스상 또는 과립상의 결명자 추출물을 얻고자 한 것이다. 결명자 중에 함유된 유효성분들은 oxyanthraquinone(

Figure kpo00001
)의 유도체들로 극성기인 -OH 기나 -COOH 기를 가지고 있고 분자의 일부에는 CH3-, CH3O-를 가지고 있어서 극성물질과 비극성물질을 공히 녹일수 있는 용제가 이상적이다. 이러한 용제들은 아세톤(acetone), 메탄올(methanol), 에탄올(ethanol)을 들수 있으나 에탄올을 제외하고는 잔유물질이 유해하므로 결명자 추출물을 얻기 위해서는 에탄올이 적합하다. 본 발명에서는, 결명자내의 약리적 성분을 추출하기 위한 용제로서 에탄올을 사용하되, 정선된 결명자를 150-210℃에서 수분간 배소한후 5-10메쉬로 분쇄한 결명자 가루에다 농도가 30-50%인 에탄올을 상기 결명자 가루의 중량에 대하여 부피가 5-10배되게 첨가하여 12-24시간동안 가끔 교반하면서 약리적 성분을 추출하는 것이며, 또한, 경제적인 추출을 하기 위하여, 정선된 결명자를 150-210℃에서 수분간 배소한후 5-10메쉬로 분쇄하여 일차로 물을 가한 후 100℃로 끓여 수 추출액을 얻고, 이때 발생한 결명자박에다 농도가 30-50%인 에탄올을 상기 결명자 가루의 중량에 대하여 부피가 3-4배되게 첨가하여 12-24시간동안 교반하면서 이차추출하여 에탄올 추출액을 얻는 것을 특징으로 하는 결명자 추출물의 제조방법을 제공하고자 하는 것이다.The present invention is to solve this drawback, that is to extract a large amount of pharmacological components in the Clarifier at room temperature almost in a large amount, the clearness of the extraction solution is excellent filtration process is easy, at the same time excellent antiseptic, good storage ability To obtain a phase or granular extract of the defect. The active ingredients contained in the deficiency are oxyanthraquinone (
Figure kpo00001
Derivatives of) have polar groups -OH group or -COOH group, and some of the molecules have CH 3- , CH 3 O-, so the solvent that can dissolve both polar and non-polar materials is ideal. These solvents may include acetone, methanol and ethanol. However, except for ethanol, residual substances are harmful, so ethanol is suitable for obtaining a deficiency extract. In the present invention, ethanol is used as a solvent for extracting pharmacological components in the cultivars, but the concentration of the spermatozoa pulverized with 5-10 mesh after roasting the selected spermatozoa at 150-210 ° C. for several minutes is 30-50%. Ethanol is added to a volume of 5 to 10 times the weight of the grains of the clarifier to extract the pharmacological component with occasional stirring for 12-24 hours, and also, in order to economically extract, the selected deflector 150-210 ℃ After roasting for several minutes at 5-10 mesh pulverized water was added first and then boiled at 100 ℃ to obtain a water extract, and the ethanol of 30-50% concentration in the deficiency of the deficiency of the deficiency powder Is added to be 3-4 times to stir for 12-24 hours while stirring to provide a method for the preparation of the deflector extract, characterized in that to obtain an ethanol extract.

전술한 바와 같이, 결명자내의 약리적 성분들은 여러개의 수산기(OH)를 가지고 있어서, 에탄올로서 잘 용출되며, 동시에 에탄올은 단백질과같은 부유물을 변성시켜 불용화 되기 때문에 단백질원인의 부유물질이 발생한다 하더라도 쉽게 침전하므로, 약리적 성분이 지니는 고유한 천연성분의 색깔인 황갈색이 청명하게 나타날 뿐만 아니라 에탄올에 의한 추출액은 방부성이 좋아서 저장성이 우수하며, 장기간 저장하면서 추출액을 인스턴트화 시킬 수 있는 잇점이 있는 것이다.As mentioned above, the pharmacological components in the deflector have several hydroxyl groups (OH), which elute well as ethanol, and at the same time, ethanol is insoluble by denaturing suspended matters such as proteins, so that even if a rich substance of protein is generated, Since it precipitates, yellowish brown, which is a unique natural color of the pharmacological component, appears clearly, and the extract obtained by ethanol has good preservatives because of its preservative property, and has an advantage of allowing instant extraction of the extract during long-term storage.

또한, 상온에서 결명자중의 유효성분을 추출하기 때문에 공정관리가 쉽고, 편리하며, 방치시간이 그렇게 길지 않고도 대량의 추출액을 얻을 수 있어서 가열추출보다 경제적이다. 이렇게 얻어진 추출액은 그대로 물에 타면 결명자차가 되는 것이고, 70-80℃에서 감압농축시켜 액키스상을 얻을 수 있고 이것을 분무건조시키면 과립상이 되어 이것을 일회용으로 포장하면 쉽게 인스턴화 시킬수도 있으므로, 언제 어디서라도 손쉽게 구입할 수 있어서 결명자차를 대중화 시킬 수 있는 것이다.In addition, the process is easy, convenient, and easy to manage because it extracts the active ingredient in the defect at room temperature, it is more economical than heat extraction because a large amount of extract can be obtained without too long. The extract obtained as described above is taken as a water-free car when it is intact, and it can be concentrated under reduced pressure at 70-80 ° C to obtain an aqueous phase, and when it is spray-dried, it can be granular. It can be easily purchased and can popularize the faulty car.

이와 같은 추출물은 탄산음료화가 가능한데, 결명자 추출물을 일반적으로 방법에 의하여 제조되는 탄산음료의 원료로도 사용할 수 있는 것이다.Such extracts can be carbonated beverages, which can also be used as a raw material of carbonated beverages prepared by the method.

[실시예 1]Example 1

제1도와 제2도 1)에서와 같은 과정으로, 결명자를 150-210℃에서 배소한 후 5-10메쉬로 분쇄한 것 10g과 물 1.5l를 넣고 1시간 끓인다음 여과하여 얻은 열수 추출물(1차추출액)을 얻었다. 이때 중요한 것은 결명자중의 유효성분 추출량인데 유효성분 추출정도는 Lovibond 비색계(Tintometer Model E AF 900) 조사한 결과 적색도(R), 황색도(Y), 청색도(B), 각각 1.9, 19.9, 0.2이었다.In the same process as in FIG. 1 and FIG. 2, 1), roast the deflector at 150-210 ° C., and crush it with 5-10 mesh. 10 g of water and 1.5 l of water are added and boiled for 1 hour, followed by filtration. Tea extract). At this time, it is important to extract the active ingredient in the missing name, and the degree of extraction of the active ingredient was determined by Lovibond colorimeter (Tintometer Model E AF 900). Redness (R), yellowness (Y), and blueness (B) were 1.9, 19.9, and 0.2, respectively. It was.

[실시예 2]Example 2

제1도와 제2도의 1)공정을 거치는 과정에서 나오는 결명자박에 제2도의 2)를 거쳐 에탄올 추출액을 얻었다. 즉 결명자 중에 물에 잘 용출되지않은 Carotene, alloin, Emodin 등이 있어서 실시예 1에서 일차추출물을 얻을 때 발생되는 박에는 아직도 유효성분이 남아있게된다. 그래서 추출물을 제조시 얻어진 박에다 농도가 30-50%인 에탄올을 결명자 박의 중량에 대하여 부피가 3-4배(중량대 부피)가량 되게 첨가하여 12-24시간 추출하고 상기 비색계로 색도를 조사한 결과 적색도(R), 황색도(Y), 청색도(B)가 각각 9.9, 45.9, 1.1인 황갈색의 추출액을 얻었다. 이러한 결과는 결명자 조직중에 함유된 유효성분은 열수 추출만으로는 추출이 잘 안되는 에탄올 용해성 성분이 많다는 것을 의미한다. 이때 얻는 액을 이차 추출물(에탄올 추출물)로 하고 실시예 1에서와같이 얻은 것을 일차추출물(수 추출물)로 하여 이 일차와 이차 추출액을 합하여 제3도와 같은 탄산음료 제조과정에 따라 결명자 탄산음료를 얻은 결과 적색도(R), 황색도(Y), 청색도(B)는 각각 5.6, 25.2, 0.9로 실시예 1에서 제조한 제품보다 색도가 월등하게 높은 결과를 볼수 있다. 따라서 결명자로부터 결명자차(일명하부차)를 제조하거나 결명자 탄산음료를 제조할때는 수 추출만으로는 결명자중의 유효성분의 추출율이 매우 낮기 때문에 보다 색이 진하고 유효성분의 이용율을 높이기 위해서는 수 추출과 에탄올 추출공정을 병행, 활용할 수 있다.The ethanol extract was obtained through 2) of FIG. That is, there are Carotene, alloin, Emodin, etc., which are not well eluted in water, so that the active ingredient still remains in the foil generated when obtaining the primary extract in Example 1. Thus, the ethanol having a concentration of 30-50% was added to the gourd obtained in the preparation of the extract so that the volume was 3-4 times (weight-to-volume) with respect to the weight of the gourd gourd, and extracted for 12-24 hours. As a result, a yellowish brown extract having redness (R), yellowness (Y), and blueness (B) of 9.9, 45.9, and 1.1, respectively. These results indicate that the active ingredient contained in the defecter tissue contains a lot of ethanol soluble components that are not easily extracted by hot water extraction alone. At this time, the obtained liquid as a secondary extract (ethanol extract) and obtained as in Example 1 as a primary extract (water extract) by combining this primary and secondary extracts obtained a carbonated beverage according to the carbonated beverage manufacturing process as shown in FIG. Results The redness (R), yellowness (Y), and blueness (B) are 5.6, 25.2, and 0.9, respectively. Therefore, when manufacturing the clarifier tea (also called undercarriage) from the cultivator or the cultivating carbonated beverage, the extraction rate of the active ingredient in the cultivator is very low. Can be used in parallel.

그러나 결명자 중의 약리성분들은 100℃정도의 고온에서 1-2시간 가열하여 고온에서 추출함으로써 약리성분의 가열에 의한 약효 감소가 야기되는 문제는 있다.However, the pharmacological components of the fault is a problem that causes a decrease in efficacy by heating the pharmacological components by extracting at a high temperature by heating 1-2 hours at a high temperature of about 100 ℃.

[실시예 3]Example 3

제2도 2의 공정에 따라 제조한 결명자에 물보다 비점이 낮으며 극성이 있고 수용성 성분이나 비 수용용성 성분을 공히 용해하는 성질을 가진 에탄올 용액만을 이용하여 유효성분들을 열 파괴없이 단일 추출공정으로 냉 추출한 것이다.2, using the ethanol solution having a lower boiling point than water and having a polarity and dissolving both water-soluble and non-water-soluble components in the crystallized according to the process of FIG. Cold extracted.

즉 정선된 결명자를 150-210℃에서 수분간 배소하여 풋냄새를 제거하고, 5-10메쉬로 분쇄한 다음 결명자 가루에 30-50% 에탄올을 5-10배 가하여 실온에서 교반하면서 냉추출을 실시한 후 제2도 2)에 의해서 에탄올 추출물을 얻는다. 이때얻은 액의 색도는 적색도(R), 황색도(Y), 청색도(B)가 각각 10.6, 52.2, 1.1로 유효성분의 고유색인 황색도가 높은 것으로 보아 유효성분의 추출효과가 높은 조건임을 알 수 있다.In other words, the selected deflector was roasted for several minutes at 150-210 ° C. to remove the odor, pulverized with 5-10 mesh, and 5-10 times 30-50% ethanol was added to the deflector powder, followed by cold extraction while stirring at room temperature. After 2) to obtain an ethanol extract. The chromaticity of the liquid obtained at this time is red (R), yellow (Y), and blue (B) of 10.6, 52.2, and 1.1, respectively. It can be seen that.

또한 이 공정으로 얻은 추출물은 극성을 가지는 성분과 극성을 가지지 않는 성분을 함유하게 되어 물 추출때처럼 고온 추출이 아닌 냉침법을 활용하기 때문에 약리효과가 큰 추출물이 된다.In addition, the extract obtained by this process contains a component having a polarity and a component having no polarity, so that the extract has a large pharmacological effect because it uses a cold acupuncture method rather than a high temperature extraction as in water extraction.

Claims (2)

정선된 결명자를 150-210℃에서 수분간 배소한 후 5-10메쉬로 분쇄하여 물을 가한 후 끓여 수 추출액을 얻고 이때 발생한 결명자박에다 농도가 30-50%인 에탄올을 상기 결명자 박의 중량에 대하여 부피가 3-4배 되게 첨가하여 12-24시간동안 교반하면서 이차추출액(에탄올 추출액)을 얻는 것을 특징으로 하는 결명자 추출물의 제조방법.The selected crystallizer was roasted at 150-210 ℃ for several minutes, pulverized with 5-10 mesh, added with water, boiled to obtain a water extract, and the ethanol having a concentration of 30-50% was added to the weight of the crystallizer foil. Method for producing a deflector extract, characterized in that to obtain a secondary extract (ethanol extract) while stirring for 12-24 hours by adding a volume 3-4 times the relative volume. 정선된 결명자를 150-210℃에서 수분간 배소한후 5-10메쉬로 분쇄한 결명자 가루에다 농도가 30-50%인 에탄올을 상기 결명자 가루에 대하여 부피가 5-10배 되게 첨가하여 추출액을 얻는 것을 특징으로 하는 결명자 추출물의 제조방법.The selected crystallizer was roasted at 150-210 ° C. for several minutes, and then ethanol having a concentration of 30-50% was added to the crystallized powder, which was pulverized with 5-10 mesh, to obtain the extract liquid by 5-10 times the volume of the crystallized powder. Method for producing a Clarifier extract, characterized in that.
KR1019870010208A 1987-09-15 1987-09-15 Process for axtraction of cassia tora l. KR900001072B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870010208A KR900001072B1 (en) 1987-09-15 1987-09-15 Process for axtraction of cassia tora l.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870010208A KR900001072B1 (en) 1987-09-15 1987-09-15 Process for axtraction of cassia tora l.

Publications (2)

Publication Number Publication Date
KR890004615A KR890004615A (en) 1989-05-09
KR900001072B1 true KR900001072B1 (en) 1990-02-26

Family

ID=19264484

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870010208A KR900001072B1 (en) 1987-09-15 1987-09-15 Process for axtraction of cassia tora l.

Country Status (1)

Country Link
KR (1) KR900001072B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101600884B1 (en) * 2014-09-26 2016-03-09 해남자연농업영농조합법인 Composition for improving, treating or preventing constipation comprising Cassia fermented by lactic acid bacteria as an active ingredient

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100344325B1 (en) * 1998-05-02 2002-11-18 주식회사 태평양 Tea product improving constipation and production thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101600884B1 (en) * 2014-09-26 2016-03-09 해남자연농업영농조합법인 Composition for improving, treating or preventing constipation comprising Cassia fermented by lactic acid bacteria as an active ingredient

Also Published As

Publication number Publication date
KR890004615A (en) 1989-05-09

Similar Documents

Publication Publication Date Title
CN100421567C (en) Instant pu'er tea and its preparation method
CN104738270B (en) A kind of clarification type lemon herbal tea and preparation method thereof
CN112603971B (en) Cordyceps militaris and pericarpium citri reticulatae traditional Chinese medicine composition, preparation method and application thereof
CN102048167A (en) Additive of radiation-resistant functional beverage, and additive-containing barley green milk wine and tea beverage
CN111066927A (en) Noni fruit health-care tea and preparation method and application thereof
CN103300180A (en) Health tea capable of reducing blood pressure as well as blood fat and preparation method thereof
KR102145252B1 (en) Diet coffee beverage composition and method of preparing coffee beverage
AU704359B2 (en) Process for producing coffee extract
JP4521703B2 (en) Lipase inhibitor obtained from hops
CN109601673A (en) Clarification type ground coffee and preparation method thereof
KR900001072B1 (en) Process for axtraction of cassia tora l.
CN109053849B (en) Comprehensive utilization method of dogwood
KR101086348B1 (en) process of manufacturing Korean medicine
CN103652158A (en) Instant molecular herbal tea of lotus leaf-mulberry leaf-chrysanthemum tea
CN101002825B (en) Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia
CN102613347A (en) Gingko black tea and preparation method thereof
CN1568833B (en) Eucommia instant tea
KR0183436B1 (en) Pueraria starch containing drinking water composition
KR20040085607A (en) A green tea coffee consisting of green tea extract and coffee extract
JP2860494B2 (en) Aging control instant powdered tea and its manufacturing method
CN111642597A (en) Medlar and olive tea beverage and preparation method thereof
CN111345377A (en) Preparation method of lithocarpus polystachyus rehd plant beverage formula
KR101716342B1 (en) Extralation process for anthocyanidin from the sorghum
CN105380267B (en) A kind of functional food and preparation method thereof
KR100375916B1 (en) A Angelicae Tenuissimae Radix jelly and the manufacturing method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee